-
Today, 2 pharmaceutical companies are listed on the market, starting a new journey
Time of Update: 2022-09-30
According to the data, Enwei Pharmaceutical is mainly engaged in the research and development, production and sales of proprietary Chinese medicines and chemical drugs, focusing on gynecological products, pediatric drugs, respiratory system drugs and other fields.
-
The next city for 10 billion drugs: NASH drugs
Time of Update: 2022-09-30
On the evening of September 22, China Biopharmaceutical announced that Chia Tai Tianqing, a subsidiary of the company, signed an agreement with the French Inventiva (IVA) company to obtain the exclusive licensing rights of the IVA treatment of non-alcoholic steatohepatitis treatment drug lanifibranor in Greater China, and the drug was certified by the US FDA as a "breakthrough therapy".
-
There are 74 A-share listed Chinese medicine companies, with a total revenue of 171.8 billion yuan in the first half of the year
Time of Update: 2022-09-30
For example, since the 13th Five-Year Plan, the cause of traditional Chinese medicine has been elevated to a national strategy; In July 2017, the "Chinese Medicine Law" was officially implemented, and the Chinese medicine industry entered a new historical period of development and governance according to law; In October 2019, the state put forward 20 more guiding opinions to promote the innovative development of traditional Chinese medicine.
-
Carry out special treatment of oral implant medical service charges and consumables prices
Time of Update: 2022-09-21
According to the website of the National Medical Insurance Bureau, the National Medical Security Bureau issued the "Notice on Carrying out Special Governance of Oral Implant Medical Service Charges a
-
Orthopedic Spine Country Is Coming! 169 companies received admission tickets, and the price reduction is expected to start from 40%.
Time of Update: 2022-09-21
On September 7, the Joint Procurement Office of High-value Medical Consumables of the National Organization issued the "National Organization orthopedic Spine Consumables Centralized Procurement Document", which clearly stated that the declaration materials would be submitted by the enterprise on September 27 and the bid would be opened on the spot.
-
In September 2022, Beijing designated medical institutions dynamically managed related matters
Time of Update: 2022-09-21
Medical security agencies in various districts and relevant designated medical institutions: In order to strengthen the management of the agreement of designated medical institutions in our city, acc
-
The State Food and Drug Administration issued guidance on strengthening the hierarchical supervision of medical device production and operation
Time of Update: 2022-09-21
According to the news on the website of the State Food and Drug Administration on September 9, the Comprehensive Department of the State Food and Drug Administration issued guidance on strengthening t
-
Wild mutant species and then let go of the expansion? Look at The White And!
Time of Update: 2022-09-21
Since 2010, the domestication of wild Chinese medicinal materials has become a hot spot in the industry. In recent years, some wild varieties have been successfully domesticated, solving the problem
-
The price control target of implant dental medical services in tertiary public hospitals is 4500 yuan per piece
Time of Update: 2022-09-21
The National Medical Insurance Bureau issued the "Notice on Carrying out Special Governance of Oral Implant Medical Service Charges and Consumables Prices" on the 8th, which clarified that the total price of a single conventional dental implant medical service in tertiary public hospitals should not exceed 4500 yuan in principle.
-
Beijing: Influenza vaccination The specific time of the three batches of vaccination is determined
Time of Update: 2022-09-21
The second batch will start in late September, mainly for students in primary and secondary schools, secondary professional schools and technical colleges, and start the self-funded vaccination of influenza vaccine at the same time.
-
Shanghai implements the "Long-term Prescription Management Norms (Trial)"
Time of Update: 2022-09-21
District Health Commissions, Medical Insurance Bureaus, Shenkang Hospital Development Center, relevant universities, The China Welfare Association, the Shanghai Municipal Health Commission Supervisio
-
Kunming, Yunnan: The city's retail pharmacies have suspended the sale of "one withdrawal and two antibodies" drugs
Time of Update: 2022-09-21
According to the needs of the epidemic prevention and control work in Kunming, in order to effectively protect the health and life safety of the public, the relevant matters are hereby notified as follows: First, since 00:00 on September 9, all retail pharmacies in the city (including online sales) have completely suspended the sale of "one return and two antibody" drugs (including fever reduction, cough, antiviral and antibiotics).
-
News Observation: Cracking the "Expensive To See a Doctor" More good drugs have been included in the medical insurance drug list
Time of Update: 2022-09-21
Pharmaceutical enterprise health standard medicine The National Medical Insurance Bureau recently announced the results of the preliminary examination of the 2022 National Medical Insurance Drug Catalogue, and a total of 344 drugs passed the preliminary formal examination, and the number of declared and approved drugs increased compared with last year.
-
General Office of the State Council: Further strengthen the control of excessive packaging of goods
Time of Update: 2022-09-21
(The Ministry of Industry and Information Technology, the State Administration of Market Regulation and other departments and local people's governments are responsible for the division of labor according to their duties) urge commodity producers to strictly comply with the requirements of the Standardization Law, and disclose the numbers and names of mandatory standards, recommended standards, group standards or enterprise standards related to packaging that they implement.
-
National Health Commission: Supervision of the whole process of nucleic acid testing Carry out normalized nucleic acid testing
Time of Update: 2022-09-21
Health On the afternoon of September 8, the joint prevention and control mechanism of the State Council held a press conference to introduce the scientific and accurate epidemic prevention and control situation and answer questions from the media.
-
Guangxi Food and Drug Administration: Three months! The special rectification of online drug sales is coming
Time of Update: 2022-09-21
Recently, the Guangxi Food and Drug Administration issued a notice to carry out a three-month special action for the supervision of the drug network market in the whole region, focusing on rectifying
-
In 2022, Eddy Pharmaceutical's "Spark of Fire" plan is in full swing
Time of Update: 2022-09-20
flat In 2022, Eddy Pharmaceutical's "Spark of Fire" plan was launched, and public welfare activities were held in major pharmacies and communities across the country to care for constipation patients, and to provide them with customized cotton bags and constipation knowledge warm reminder cards.
-
This kind of hypoglycemic drug outbreak! Aosaikang successfully broke through, and Hengrui 1 class 1 new drug sprint
Time of Update: 2022-09-14
Recently, the research and development of new oral hypoglycemic drug DPP-4 inhibitors in China has ushered in good news: HSK7653 tablets of HiSco and plumagliptin tablets of CSPC Have completed two p
-
Pharmaceutical companies continue to lay out the ADC market, and an innovation war is inevitable
Time of Update: 2022-09-14
Huadong Pharmaceutical said that by carrying out equity investment and product cooperation with Heidelberg Pharma, an emerging technology company in the field of ADC, and introducing a number of ADC innovative products, the company will further enrich the pipeline of innovative products in the field of oncology and achieve a differentiated in-depth layout in the field of ADC.
-
Measures for the Supervision and Administration of Drug Network Sales
Time of Update: 2022-09-14
Article 5: Engaging in online drug sales and providing drug online trading platform services shall employ effective measures to ensure that the information in the whole process of the transaction is true, accurate, complete, and traceable, and comply with the relevant provisions of the State on the protection of personal information.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
